nach oben

Critical Care

Erschienen in:

01.06.2012 | Commentary

Tranexamic acid: less bleeding and less thrombosis?

verfasst von: Anne Godier, Ian Roberts, Beverley J Hunt

Erschienen in: Critical Care | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

The early administration of tranexamic acid (TXA) to bleeding trauma patients reduces all-cause mortality without increasing the risk of vascular occlusive events. Indeed, the risk of arterial thrombosis appears to be reduced with TXA. In this commentary we hypothesize that TXA has an antithrombotic effect and explore potential mechanisms. These include inhibition of the inflammatory effects of plasmin, effects on platelets and effects on factors V and VIII. If proven, these antithrombotic effects would have major implications for the systemic use of TXA in surgical patients, where TXA has been clearly shown to reduce bleeding.

Ker K, Edwards P, Perel P, Shakur H, Roberts I: Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012, 344: e3054. 10.1136/bmj.e3054PubMedCentralCrossRefPubMed

CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T: The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011, 377: 1096-1101. 1101.e1-2CrossRef

Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet JF: Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008, 64: 1211-1217. discussion 1217 10.1097/TA.0b013e318169cd3cCrossRefPubMed

Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, Perez R, Brouard M, Milena A, Martinez R, Mora ML: Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care 2007, 11: R117. 10.1186/cc6173PubMedCentralCrossRefPubMed

Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P: Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004, 351: 2611-2618. 10.1056/NEJMoa041747CrossRefPubMed

Ng JL, Chan MT, Gelb AW: Perioperative stroke in noncardiac, nonneurosurgical surgery. Anesthesiology 2011, 115: 879-890. 10.1097/ALN.0b013e31822e9499CrossRefPubMed

Laumonnier Y, Syrovets T, Burysek L, Simmet T: Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. Blood 2006, 107: 3342-3349. 10.1182/blood-2005-07-2840CrossRefPubMed

Wygrecka M, Marsh LM, Morty RE, Henneke I, Guenther A, Lohmeyer J, Markart P, Preissner KT: Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 2009, 113: 5588-5598. 10.1182/blood-2008-08-170837CrossRefPubMed

Lighvani S, Baik N, Diggs JE, Khaldoyanidi S, Parmer RJ, Miles LA: Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT. Blood 2011, 118: 5622-5630. 10.1182/blood-2011-03-344242PubMedCentralCrossRefPubMed

10.

Burysek L, Syrovets T, Simmet T: The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. J Biol Chem 2002, 277: 33509-33517. 10.1074/jbc.M201941200CrossRefPubMed

11.

Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, et al.: Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987, 76: 142-154. 10.1161/01.CIR.76.1.142CrossRefPubMed

12.

Quinton TM, Kim S, Derian CK, Jin J, Kunapuli SP: Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4. J Biol Chem 2004, 279: 18434-18439. 10.1074/jbc.M401431200CrossRefPubMed

13.

Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, Acker B, Brückner UB, Nilsson B, Gebhard F, Lambris JD, Huber-Lang M: Molecular intercommunication between the complement and coagulation systems. J Immunol 2010, 185: 5628-5636. 10.4049/jimmunol.0903678PubMedCentralCrossRefPubMed

14.

Ogiwara K, Nogami K, Nishiya K, Shima M: Plasmin-induced procoagulant effects in the blood coagulation: a crucial role of coagulation factors V and VIII. Blood Coagul Fibrinolysis 2010, 21: 568-576. 10.1097/MBC.0b013e32833c9a9fCrossRefPubMed

15.

Lee CD, Mann KG: Activation/inactivation of human factor V by plasmin. Blood 1989, 73: 185-190.PubMed

16.

Nogami K, Shima M, Matsumoto T, Nishiya K, Tanaka I, Yoshioka A: Mechanisms of plasmin-catalyzed inactivation of factor VIII: a crucial role for proteolytic cleavage at Arg336 responsible for plasmin-catalyzed factor VIII inactivation. J Biol Chem 2007, 282: 5287-5295.CrossRefPubMed

17.

Li A, Wun TC: Proteolysis of tissue factor pathway inhibitor (TFPI) by plasmin: effect on TFPI activity. Thromb Haemost 1998, 80: 423-427.PubMed

18.

Stalboerger PG, Panetta CJ, Simari RD, Caplice NM: Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor. Thromb Haemost 2001, 86: 923-928.PubMed

19.

Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH: Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 2005, 173: 627-634. doi:10.1186/cc11374 10.1503/cmaj.050011PubMedCentralCrossRefPubMed

Titel: Tranexamic acid: less bleeding and less thrombosis?
verfasst von: Anne Godier
Ian Roberts
Beverley J Hunt
Publikationsdatum: 01.06.2012
Verlag: BioMed Central
Erschienen in: Critical Care / Ausgabe 3/2012
Elektronische ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc11374

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Tranexamic acid: less bleeding and less thrombosis?

Abstract

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Electrocardiographic changes in therapeutic hypothermia

Clinical review: Clinical imaging of the sublingual microcirculation in the critically ill - where do we stand?

Obese trauma patients are at increased risk of early hypovolemic shock: a retrospective cohort analysis of 1,084 severely injured patients

Antipsychotic use and diagnosis of delirium in the intensive care unit

Combining intermediate levels of the Endotoxin Activity Assay (EAA) with other biomarkers in the assessment of patients with sepsis: results of an observational study

Insulin therapy improves protein metabolism in the critically ill

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS